Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nutra Pharma's revenue for the twelve months ending Jun 30, 2026 was $160.82K, down 49.0% year over year. For fiscal 2025 it was $257.61K, up 4.6% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $1.43M in fiscal 2010.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $257.61K | +4.6% |
| FY2024 | Dec 31, 2024 | $246.31K | +19.8% |
| FY2023 | Dec 31, 2023 | $205.56K | +41.0% |
| FY2022 | Dec 31, 2022 | $145.80K | +49.2% |
| FY2021 | Dec 31, 2021 | $97.74K | +88.3% |
| FY2020 | Dec 31, 2020 | $51.90K | -50.3% |
| FY2019 | Dec 31, 2019 | $104.39K | -20.1% |
| FY2018 | Dec 31, 2018 | $130.60K | +7.9% |
| FY2017 | Dec 31, 2017 | $120.98K | -28.1% |
| FY2016 | Dec 31, 2016 | $168.36K | -42.2% |
| FY2015 | Dec 31, 2015 | $291.30K | -51.0% |
| FY2014 | Dec 31, 2014 | $594.51K | +467.1% |
| FY2013 | Dec 31, 2013 | $104.84K | -48.4% |
| FY2012 | Dec 31, 2012 | $203.29K | +27.4% |
| FY2011 | Dec 31, 2011 | $159.60K | -88.9% |
| FY2010 | Dec 31, 2010 | $1.43M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.46K | -59.2% |
| Q1 FY2026 | Mar 31, 2026 | $27.25K | -63.2% |
| Q4 FY2025 | Dec 31, 2025 | $28.86K | -64.7% |
| Q3 FY2025 | Sep 30, 2025 | $70.24K | -6.3% |
| Q2 FY2025 | Jun 30, 2025 | $84.53K | +63.5% |
| Q1 FY2025 | Mar 31, 2025 | $73.97K | +96.1% |
| Q4 FY2024 | Dec 31, 2024 | $81.87K | +74.1% |
| Q3 FY2024 | Sep 30, 2024 | $74.99K | +45.3% |
| Q2 FY2024 | Jun 30, 2024 | $51.71K | -1.3% |
| Q1 FY2024 | Mar 31, 2024 | $37.73K | -30.8% |
| Q4 FY2023 | Dec 31, 2023 | $47.03K | -40.5% |
| Q3 FY2023 | Sep 30, 2023 | $51.61K | +109.6% |
| Q2 FY2023 | Jun 30, 2023 | $52.40K | +84.3% |
| Q1 FY2023 | Mar 31, 2023 | $54.52K | +296.3% |
| Q4 FY2022 | Dec 31, 2022 | $78.99K | +203.9% |
| Q3 FY2022 | Sep 30, 2022 | $24.62K | +27.8% |
| Q2 FY2022 | Jun 30, 2022 | $28.43K | -6.7% |
| Q1 FY2022 | Mar 31, 2022 | $13.76K | -37.5% |
| Q4 FY2021 | Dec 31, 2021 | $25.99K | +71.3% |
| Q3 FY2021 | Sep 30, 2021 | $19.27K | +44.1% |
| Q2 FY2021 | Jun 30, 2021 | $30.46K | +388.1% |
| Q1 FY2021 | Mar 31, 2021 | $22.02K | +28.7% |
| Q4 FY2020 | Dec 31, 2020 | $15.17K | +39.2% |
| Q3 FY2020 | Sep 30, 2020 | $13.37K | -68.1% |
| Q2 FY2020 | Jun 30, 2020 | $6.24K | -38.9% |
| Q1 FY2020 | Mar 31, 2020 | $17.12K | -58.6% |
| Q4 FY2019 | Dec 31, 2019 | $10.89K | -58.5% |
| Q3 FY2019 | Sep 30, 2019 | $41.96K | -4.6% |
| Q2 FY2019 | Jun 30, 2019 | $10.22K | -65.2% |
| Q1 FY2019 | Mar 31, 2019 | $41.32K | +27.2% |
| Q4 FY2018 | Dec 31, 2018 | $26.27K | -19.8% |
| Q3 FY2018 | Sep 30, 2018 | $43.97K | +158.9% |
| Q2 FY2018 | Jun 30, 2018 | $29.38K | -4.2% |
| Q1 FY2018 | Mar 31, 2018 | $32.48K | -13.1% |
| Q4 FY2017 | Dec 31, 2017 | $32.77K | – |
| Q1 FY2017 | Mar 31, 2017 | $16.98K | – |
| Q2 FY2016 | Jun 30, 2016 | $30.68K | – |
| Q1 FY2016 | Mar 31, 2016 | $37.39K | – |
See a number that looks wrong?